Pub. Date : 2010 Jun
PMID : 20394470
5 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Co-possession of phosphodiesterase type-5 inhibitors (PDE5-I) with nitrates. | Nitrates | phosphodiesterase 5A | Homo sapiens |
| 2 | OBJECTIVE: Estimate the proportion of phosphodiesterase type-5 inhibitor (PDE5-I) patients who co-possess nitrates and compare the proportion of tadalafil patients dispensed nitrates to a matched control group. | Nitrates | phosphodiesterase 5A | Homo sapiens |
| 3 | When co-possessed prescriptions were defined by overlapping exposure periods, the proportion of PDE5-I patients with co-possessed nitrates ranged from 1.44% (tadalafil) to 1.72% (vardenafil) and 2.13% (sildenafil). | Nitrates | phosphodiesterase 5A | Homo sapiens |
| 4 | The majority (54.29%) of co-possessed PDE5-I and nitrate prescriptions had the nitrate dispensed prior to the PDE5-I prescription identified in the study cohort. | Nitrates | phosphodiesterase 5A | Homo sapiens |
| 5 | The majority (54.29%) of co-possessed PDE5-I and nitrate prescriptions had the nitrate dispensed prior to the PDE5-I prescription identified in the study cohort. | Nitrates | phosphodiesterase 5A | Homo sapiens |